Abstract
Neoplasms include several hundreds of diseases, which can be distinguished by localization, morphology, clinical behaviour and response to therapy. The number of new cases of cancer which occurred worldwide in 2008 has been estimated at about 12,700,000. Of these, 6,600,000 occurred in men and 6,000,000 in women. About 5,600,000 cases occurred in high-income countries (North America, Japan, Europe including Russia, Australia and New Zealand) and 7,100,000 in low- and middle-income countries. Among men, lung, stomach, colorectal, prostate and liver cancer s are the most common malignant neoplasms, while breast, colorectal, cervical, lung and stomach are the most common neoplasms among women. Analytical studies have shown the causal role of several exposures in the aetiology of malignant neoplasms: The major causes of human cancer are tobacco smoking, dietary factors, obesity, alcohol drinking, infectious agents, occupation and pollution, reproductive factors and exogenous hormones, perinatal and growth factors, ionizing and nonionizing radiations, medical procedures and drugs, besides genetic factors. Consequently, the prevention of cancer includes primary and secondary prevention programmes. The main goal of primary prevention is to reduce the incidence of cancer through the reduction of exposure to risk factors for cancer at the population level, while secondary prevention takes place through the early detection of cancer. Where feasible, primary prevention programmes are largely cost-effective, i.e. the reduction of the burden of disease is achieved with a reasonable money investment, while this is not always the case for secondary prevention programmes. In this chapter, we aim to describe the current burden of cancer and the main health policies available, in order to provide key elements for public health professionals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Boffetta P, Boccia S, La Vecchia C (2014) A quick guide to cancer epidemiology. Springer Switzerland
WHO (1990) International classification of diseases for oncology (ICD-O), 2nd edn. Springer brief in cancer research, World Health Organization, Geneva
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917
Baili P, Micheli A, De Angelis R et al (2008) Life tables for world-wide comparison of relative survival for cancer (CONCORD study). Tumori 94:658–668
Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R (2009) EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 45:931–991
Sankaranarayanan R, Swaminathan R, Jayant K, Brenner H (2011) An overview of cancer survival in Africa, Asia, the Caribbean and Central America: the case for investment in cancer health services. IARC Sci Publ (162):257–291
Soerjomataram I, Lortet-Tieulent J, Parkin DM et al (2012) Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380:1840–1850
IARC (2004) Tobacco smoke and involuntary smoking. In: IARC monographs on the evaluation of the carcinogenic risks to humans, vol 83. IARC, Lyon, pp 51–1187
Doll R, Peto R (2005) Epidemiology of cancer. In: Warell DA, Cox TM, Firth JD (eds) Oxford textbook of medicine, vol 3, 4th edn. Oxford University Press, New York, pp 193–218
Doll R, Peto R, Boreham J, Sutherland I (2004) Mortality in relation to smoking: 50 years’ observations on male British doctors. Br Med J 328:1519
Jha P, Ramasundarahettige C, Landsman V et al (2013) 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 368:341–350
Pirie K, Peto R, Reeves GK, Green J, Beral V (2013) The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 381:133–141
Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. Br Med J 321:323–329
Bosetti C, Gallus S, Peto R et al (2008) Tobacco smoking, smoking cessation, and cumulative risk of upper aerodigestive tract cancers. Am J Epidemiol 167:468–473
La Vecchia C, Bosetti C, Lucchini F et al (2010) Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol 21:1323–1360
Bosetti C, Malvezzi M, Rosso T et al (2012) Lung cancer mortality in European women: trends and predictions. Lung Cancer 78:171–178
Malvezzi M, Bosetti C, Rosso T et al (2013) Lung cancer mortality in European men: trends and predictions. Lung Cancer 80:138–145
Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999) The European mesothelioma epidemic. Br J Cancer 79:666–672
Song Y, Zhao L, Palipudi KM et al (2013) Tracking MPOWER in 14 countries: results from the Global Adult Tobacco Survey, 2008–2010. Glob Health Promot
Mendez D, Alshanqeety O, Warner KE (2013) The potential impact of smoking control policies on future global smoking trends. Tob Control 22:46–51
Bertuccio P, La Vecchia C, Silverman DT et al (2011) Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 22:1420–1426
Alexander DD, Morimoto LM, Mink PJ, Lowe KA (2010) Summary and meta-analysis of pro-spective studies of animal fat intake and breast cancer. Nutr Res Rev 23:169–179
Liu L, Zhuang W, Wang RQ et al (2011) Is dietary fat associated with the risk of colorectal cancer? A meta-analysis of 13 prospective cohort studies. Eur J Nutr 50:173–184
Chan DS, Lau R, Aune D et al (2011) Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One 6:e20456
Wu S, Feng B, Li K et al (2012) Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. Am J Med 125:551–559.e5
Aune D, Lau R, Chan DS et al (2012) Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol 23:37–45
Chen GC, Pang Z, Liu QF (2012) Magnesium intake and risk of colorectal cancer: a meta-analysis of prospective studies. Eur J Clin Nutr 66:1182–1186
WCRF (2007) World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC
Pelucchi C, Bosetti C, Rossi M, Negri E, La Vecchia C (2009) Selected aspects of Mediterranean diet and cancer risk. Nutr Cancer 61:756–766
IARC (1998) Vitamin A. In: IARC handbooks of cancer prevention, vol 3. pp 1–261. IARC Publications, IARC, Lyon
IARC (1998) Carotenoids. In: IARC handbooks of cancer prevention, vol 2. pp 1–326. IARC Publications, IARC, Lyon
IARC (2008) Vitamin D and cancer/a report of the IARC working group on vitamin D, vol 5. IARC, Lyon
IARC (2002) Weight control and physical activity. In: IARC handbooks of cancer prevention, vol 6. pp 1–315. IARC Publications, IARC, Lyon
Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO (2001) Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91:421–430
Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT (2012) Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 380:219–229
Baan R, Straif K, Grosse Y et al (2007) Carcinogenicity of alcoholic beverages. Lancet Oncol 8:292–293
Pelucchi C, Tramacere I, Boffetta P, Negri E, La Vecchia C (2011) Alcohol consumption and cancer risk. Nutr Cancer 63:983–990
Bagnardi V, Rota M, Botteri E et al (2013) Light alcohol drinking and cancer: a meta-analysis. Ann Oncol 24:301–308
Boffetta P, Hashibe M (2006) Alcohol and cancer. Lancet Oncol 7:149–156
Boyle P, Autier P, Bartelink H et al (2003) European Code Against Cancer and scientific justification: third version (2003). Ann Oncol 14:973–100
de Martel C, Ferlay J, Franceschi S et al (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607–615
Schottenfeld D, Beebe-Dimmer JL, Buffler PA, Omenn GS (2013) Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors. Annu Rev Public Health 34:97–117
La Vecchia C, Boffetta P (2012) Role of stopping exposure and recent exposure to asbestos in the risk of mesothelioma. Eur J Cancer Prev 21:227–230
IARC (2007) Combined estrogen-progestogen contraceptives and combined estrogen progestogen menopausal therapy. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol 91. IARC monographs, IARC, Lyon
Cibula D, Gompel A, Mueck AO et al (2010) Hormonal contraception and risk of cancer. Hum Reprod Update 16:631–650
Harvard Center for Cancer Prevention (1996) Harvard report on cancer prevention. Volume 1: causes of human cancer. Cancer Causes Control 7(Suppl 1):S3–59
Trichopoulos D (1990) Hypothesis: does breast cancer originate in utero? Lancet 335:939–940
IARC (2000) X-radiation and y-radiation. In: IARC monographs on the evaluation of carcinogenic risks to humans. Ionizing radiation, part 1: X- and Gamma (y)-radiation, and neutrons, vol 75. pp 121–362, IARC monographs, IARC, Lyon
Chang E, Adami HO, Bailey WH et al (2014) Validity of geographically modeled environmental exposure estimates. Critical Rev Toxicol
Cuzick J, Otto F, Baron JA et al (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10:501–507
Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C (2012) Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol 23:1403–1415
Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomized trials. Lancet 377:31–41
Vineis P, Manuguerra M, Kavvoura FK et al (2009) A field synopsison low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 101:24–36
Stadler ZK, Thom P, Robson ME et al (2010) Genome-wide association studies of cancer. J Clin Oncol 28:4255–4267
Peto R, Gray R, Brantom P, Grasso P (1991) Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res 51:6415–6451
Peto R (1977) Epidemiology, multistage models and short-term mutagenicity tests. In: Hiatt HH, Watson JD, Winsten JA (eds) Origins of human cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 1403–1428
Greenwald P (2005) Lifestyle and medical approaches to cancer prevention. Recent Results Cancer Res 166:1–15
Boffetta P, La Vecchia C (2009) Neoplasms. In: Detels R, Beaglehole R, Lansang MA, Gulliford M (eds) The practice of public health. Oxford textbook of public health, vol 3, 5th edn. Oxford University Press, New York, pp 997–1020
Zhang Z-F, Boffetta P, Neugut AI, La Vecchia C (2014) Cancer epidemiology and public health. In: Oxford textbook of public health. Oxford University Press, Oxford
Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409
IUKPBCS (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380:1778–1786
Anttila A, Sarkeala T, Hakulinen T, Heinavaara S (2008) Impacts of the Finnish service screening programme on breast cancer rates. BMC Public Health 8:38
Kalager M, Zelen M, Langmark F, Adami HO (2010) Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 363:1203–1210
Boyle P, Brawley OW (2009) Prostate cancer: current evidence weighs against population screening. CA Cancer J Clin 59:220–224
Welch HG, Albertsen PC (2009) Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J Natl Cancer Inst 101:1325–1329
FUTURE II Study Group (2007) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356:1915–1927
Cuzick J (2010) Long-term cervical cancer prevention strategies across the globe. Gynecol Oncol 117:S11–S14
Smith RA, Brooks D, Cokkinides V, Saslow D, Brawley OW (2013) Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin 63:88–105
Sigurdsson JA, Getz L, Sjonell G, Vainiomaki P, Brodersen J (2013) Marginal public health gain of screening for colorectal cancer: modelling study, based on WHO and national databases in the Nordic countries. J Eval Clin Pract 19:400–407
Sankaranarayanan R, Ramadas K, Thara S, et al (2013) Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncol 49:314–321
Steinmaus CM, Ferreccio C, Romo JA, et al (2013) Drinking water arsenic in northern Chile: high cancer risks 40 years after exposure cessation. Cancer Epidemiol Biomarkers Prev 22:623–630
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Boccia, S., La Vecchia, C., Boffetta, P. (2015). Epidemiology of Cancer and Principles of Prevention. In: Boccia, S., Villari, P., Ricciardi, W. (eds) A Systematic Review of Key Issues in Public Health. Springer, Cham. https://doi.org/10.1007/978-3-319-13620-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-13620-2_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13619-6
Online ISBN: 978-3-319-13620-2
eBook Packages: MedicineMedicine (R0)